keyword
https://read.qxmd.com/read/38688596/effect-of-sacubitril-valsartan-on-patients-having-heart-failure-with-preserved-left-ventricular-ejection-fraction-undergoing-hemodialysis-a-long-term-observational-study
#21
JOURNAL ARTICLE
Akira Mima, Hidemasa Gotoda, Shinji Lee, Rina Lee, Ami Murakami, Ryosuke Akai, Sayumi Kidooka, Keishi Matsumoto, Yuta Saito, Shinji Hishida, Takahiro Nakamoto, Suguru Kido, Takayoshi Hamada
BACKGROUND/AIM: Sacubitril/valsartan (SV), a novel pharmacological class of angiotensin receptor neprilysin inhibitors, is effective in treating heart failure (HF) by inhibiting the degradation of natriuretic peptides and the renin-angiotensin-aldosterone system. However, no studies have observed the long-term effects of SV on patients with HF and preserved left ventricular ejection fraction (LVEF) undergoing hemodialysis (HD) over a long period. PATIENTS AND METHODS: This single-center retrospective study of 21 months duration involved consecutive patients with HF and preserved LVEF undergoing HD, who received 50-200 mg/day...
2024: In Vivo
https://read.qxmd.com/read/38685456/bioactive-adrenomedullin-as-a-marker-of-congestion-and-disease-progression-in-patients-with-a-systemic-right-ventricle
#22
JOURNAL ARTICLE
Mohammad Mostafa Ansari Ramandi, Paul M Hendriks, Adriaan A Voors, Annemien E van den Bosch, Joost P van Melle
BACKGROUND: Adults with a systemic right ventricle (sRV) are at a high risk for heart failure (HF) hospitalisation and mortality. Bioactive adrenomedullin (bio-ADM) has been proposed as a marker of congestion and prognosis in patients with cardiovascular disease. We aimed to evaluate the association between bio-ADM and mortality and HF events in sRV patients. METHODS: Plasma bio-ADM was measured by a novel immunoassay in plasma of 85 sRV patients. A composite endpoint of all-cause mortality and HF events was used as outcome...
April 27, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38683441/prognostic-factors-in-patients-with-heart-failure-and-sarcopenia-an-observational-retrospective-study
#23
JOURNAL ARTICLE
Yasutaka Imamura, Atsushi Suzuki, Kazuho Kamishima, Kazuhito Suzuki, Junichi Yamaguchi
BACKGROUND: Heart failure (HF) prevalence increases with age, and sarcopenia is a poor prognostic factor in patients with HF. We aimed to evaluate the characteristics and prognostic factors in patients with HF and sarcopenia. RESULTS: We retrospectively reviewed 256 consecutive patients admitted to our hospital for HF between May 2018 and May 2021, underwent dual-energy X-ray absorptiometry, and were diagnosed with sarcopenia. The primary endpoint was all-cause mortality...
April 29, 2024: Egyptian Heart Journal: EHJ
https://read.qxmd.com/read/38681954/clinical-application-of-amino-terminal-pro-brain-natriuretic-peptide-concentration-in-amniotic-fluid-for-the-prediction-of-preterm-birth-in-symptomatic-women
#24
JOURNAL ARTICLE
Fernando A Ferrer-Marquez, Rocío P Astudillo, Jorge A Carvajal
BACKGROUND: Preterm birth accounts for 60% to 80% of neonatal mortality. Approximately one-third of preterm births are caused by the spontaneous onset of preterm labor. Nevertheless, 70% to 90% of women diagnosed with preterm labor will not deliver within 7 days. Thus, many women will be unnecessarily treated by preterm labor with risk medications. Better tools are needed to categorize women in preterm labor into high or low risk of preterm delivery. OBJECTIVE: This study aimed to evaluate the amino-terminal pro-brain natriuretic peptide concentration in the amniotic fluid as a prognostic test to predict the risk of delivery within 48 hours or 7 days and before 34 0/7 or 37 0/7 weeks of gestation in women in preterm labor...
May 2024: AJOG global reports
https://read.qxmd.com/read/38681045/serum-brain-natriuretic-peptide-levels-may-be-a-useful-marker-for-early-diagnosis-of-cardiomyopathy-secondary-to-neuroblastoma-a-case-report
#25
Natsumi Fujiyama, Osamu Matsuo, Takahiro Yamashita, Kensaku Kohrogi, Fumiya Miyamura, Tadashi Anan, Kimitoshi Nakamura
Cardiomyopathy is a rare but serious complication associated with neuroblastoma. The brain natriuretic peptide level led to a diagnosis of secondary dilated cardiomyopathy before the worsening of heart failure symptoms.
May 2024: Clinical Case Reports
https://read.qxmd.com/read/38680825/effects-of-gap-26-a-connexin-43-inhibitor-on-cirrhotic-cardiomyopathy-in-rats
#26
JOURNAL ARTICLE
Dlshad Mohammed, Seyed Mohammad Tavangar, Arash Khodadoostan, Seyyedeh Elaheh Mousavi, Ahmad-Reza Dehpour, Farahnaz Jazaeri
Introduction Cirrhotic cardiomyopathy (CCM) is recognized by impaired cardiac responsiveness to stress, prolonged QT interval, and systolic and diastolic dysfunctions. Connexins are a family of transmembrane proteins that play a key role in cardiac physiology. Connexin 43 (Cx43) inhibition showed cardio-protective effects. Peptide drug Cx43 inhibitor, Gap 26, could inhibit gap junction 43. This study was designed to evaluate the effects of a connexin mimetic peptide, Gap 26, in the CCM model in rats. Methods The cirrhosis was induced through carbon tetrachloride (CCl4)...
April 2024: Curēus
https://read.qxmd.com/read/38680475/types-of-septic-cardiomyopathy-prognosis-and-influencing-factors-a-clinical-study
#27
JOURNAL ARTICLE
Nian-Fang Lu, Hong-Xia Niu, An-Qi Liu, Ya-Lei Chen, Hu-Nan Liu, Pei-Hong Zhao, Jun Shao, Xiu-Ming Xi
OBJECTIVE: To explore the prognostic outcomes associated with different types of septic cardiomyopathy and analyze the factors that exert an influence on these outcomes. METHODS: The data collected within 24 hours of ICU admission included cardiac troponin I (cTnI), N-terminal pro-Brain Natriuretic Peptide (NT-proBNP); SOFA (sequential organ failure assessment) scores, and the proportion of vasopressor use. Based on echocardiographic outcomes, septic cardiomyopathy was categorized into left ventricular (LV) systolic dysfunction, LV diastolic dysfunction, and right ventricular (RV) systolic dysfunction...
2024: Risk Management and Healthcare Policy
https://read.qxmd.com/read/38678253/ketone-body-levels-and-its-associations-with-cardiac-markers-following-an-acute-myocardial-infarction-a-post-hoc-analysis-of-the-emmy-trial
#28
RANDOMIZED CONTROLLED TRIAL
Faisal Aziz, Norbert J Tripolt, Peter N Pferschy, Hubert Scharnagl, Mahmoud Abdellatif, Abderrahim Oulhaj, Martin Benedikt, Ewald Kolesnik, Dirk von Lewinski, Harald Sourij
BACKGROUND: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been suggested to exert cardioprotective effects in patients with heart failure, possibly by improving the metabolism of ketone bodies in the myocardium. METHODS: This post hoc analysis of the EMMY trial investigated the changes in serum β-hydroxybutyrate (3-βOHB) levels after acute myocardial infarction (AMI) in response to 26-week of Empagliflozin therapy compared to the usual post-MI treatment...
April 27, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38676758/prediction-model-for-developing-neuropsychiatric-systemic-lupus-erythematosus-in-lupus-patients
#29
JOURNAL ARTICLE
Si-Yu Feng, Lin-Chong Su, Xiao-Yan Liu, Zhen Qin, Lu Fu, An-Fang Huang, Wang-Dong Xu
OBJECTIVE: This study aimed to construct a predictive model for assessing the risk of development of neuropsychiatric systemic lupus erythematosus (NPSLE) among patients with SLE based on clinical, laboratory, and meteorological data. METHODS: A total of 2232 SLE patients were included and were randomly assigned into training and validation sets. Variables such as clinical and laboratory data and local meteorological data were screened by univariate and least absolute shrinkage and selection operator (LASSO) logistic regression modelling...
April 27, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38674214/the-initial-experience-of-balloon-pulmonary-angioplasty-for-chronic-thromboembolic-pulmonary-hypertension-in-latvia
#30
JOURNAL ARTICLE
Anna Krigere, Verners Roberts Kalejs, Ricards Kaulins, Ainars Rudzitis, Liga Bondare, Matiss Sablinskis, Aivars Lejnieks, Dana Kigitovica, Marcin Kurzyna, Andris Skride
Background : Treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or persistent pulmonary hypertension after pulmonary endarterectomy (PEA) include targeted medical therapy and balloon pulmonary angioplasty (BPA). BPA is an emerging treatment modality that has been reported to improve functional capacity, pulmonary hemodynamics, and right ventricular function. Reports from expert centers are promising, but more data are needed to make the results more generalizable. Materials and Methods : We conducted a prospective analysis of nine consecutive CTEPH patients who underwent balloon pulmonary angioplasty (BPA) sessions at Pauls Stradins Clinical University Hospital in Riga, Latvia between 1 April 2022 and 1 July 2023...
March 30, 2024: Medicina
https://read.qxmd.com/read/38668394/chronological-course-and-clinical-features-after-denver-peritoneovenous-shunt-placement-in-decompensated-liver-cirrhosis
#31
JOURNAL ARTICLE
Shingo Koyama, Asako Nogami, Masato Yoneda, Shihyao Cheng, Yuya Koike, Yuka Takeuchi, Michihiro Iwaki, Takashi Kobayashi, Satoru Saito, Daisuke Utsunomiya, Atsushi Nakajima
BACKGROUND: Refractory ascites affects the prognosis and quality of life in patients with liver cirrhosis. Peritoneovenous shunt (PVS) is a treatment procedure of palliative interventional radiology for refractory ascites. Although it is reportedly associated with serious complications (e.g., heart failure, thrombotic disease), the clinical course of PVS has not been thoroughly evaluated. OBJECTIVES: To evaluate the relationship between chronological course and complications after PVS for refractory ascites in liver cirrhosis patients...
March 25, 2024: Tomography: a Journal for Imaging Research
https://read.qxmd.com/read/38667721/in-hospital-versus-out-of-hospital-pulmonary-embolism-clinical-characteristics-biochemical-markers-and-echocardiographic-indices
#32
JOURNAL ARTICLE
Christos Ballas, Lampros Lakkas, Olga Kardakari, Eftychia Papaioannou, Konstantinos C Siaravas, Katerina K Naka, Lampros K Michalis, Christos S Katsouras
BACKGROUND: A significant proportion of pulmonary embolisms (PEs) occurs in patients during hospitalisation for another reason. However, limited data regarding differences between out-of-hospital PE (OHPE) and in-hospital PE (IHPE) is available. We aimed to compare these groups regarding their clinical characteristics, biochemical markers, and echocardiographic indices. METHODS: This was a prospective, single-arm, single-centre study. Adult consecutive patients with non-COVID-related PE from September 2019 to March 2022 were included and followed up for 12 months...
March 28, 2024: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/38667454/b-type-natriuretic-peptide-a-paradox-in-the-diagnosis-of-acute-heart-failure-with-preserved-ejection-fraction-in-obese-patients
#33
JOURNAL ARTICLE
Marius Rus, Loredana Ioana Banszki, Felicia Liana Andronie-Cioara, Oana Liliana Pobirci, Veronica Huplea, Alina Stanca Osiceanu, Gheorghe Adrian Osiceanu, Simina Crisan, Decebal Dumitru Pobirci, Madalina Ioana Guler, Paula Marian
BACKGROUND AND OBJECTIVES: B-type natriuretic peptide (BNP) represents a clinical tool for the diagnosis and prognostic evaluation of acute and chronic heart failure patients. The purpose of this retrospective study was to evaluate BNP values in obese and non-obese patients with acute heart failure with preserved ejection fraction. MATERIALS AND METHODS: In this study, we enrolled 240 patients who presented to the emergency department complaining of acute shortness of breath and fatigue...
April 12, 2024: Diagnostics
https://read.qxmd.com/read/38667440/carbohydrate-antigen-125-ca-125-a-novel-biomarker-in-acute-heart-failure
#34
REVIEW
Mihai Cristian Marinescu, Violeta Diana Oprea, Sorina Nicoleta Munteanu, Aurel Nechita, Dana Tutunaru, Luiza Camelia Nechita, Aurelia Romila
BACKGROUND: Heart failure is a global major healthcare problem with millions of hospitalizations annually and with a very high mortality. There is an increased interest in finding new and reliable biomarkers for the diagnostic, prognostic and therapeutic guidance of patients hospitalized for acute heart failure; Our review aims to summarize in an easy-to-follow flow recent relevant research evaluating the possible use and the clinical value of measuring CA 125 serum levels in acute HF...
April 10, 2024: Diagnostics
https://read.qxmd.com/read/38667166/detection-of-nt-probnp-using-optical-fiber-back-reflection-plasmonic-biosensors
#35
JOURNAL ARTICLE
Ana Sofia Assunção, Miguel Vidal, Maria João Martins, Ana Violeta Girão, Médéric Loyez, Christophe Caucheteur, José Mesquita-Bastos, Florinda M Costa, Sónia O Pereira, Cátia Leitão
Heart failure (HF) is a clinical entity included in cardiovascular diseases affecting millions of people worldwide, being a leading cause of hospitalization of older adults, and therefore imposing a substantial economic burden on healthcare systems. HF is characterized by dyspnea, fatigue, and edema associated with elevated blood levels of natriuretic peptides, such as N Terminal pro-B-type Natriuretic Peptide (NT-proBNP), for which there is a high demand for point of care testing (POCT) devices. Optical fiber (OF) biosensors offer a promising solution, capable of real-time detection, quantification, and monitoring of NT-proBNP concentrations in serum, saliva, or urine...
April 4, 2024: Biosensors
https://read.qxmd.com/read/38659585/efficacy-and-safety-of-shen-gui-capsules-for-chronic-heart-failure-a-systematic-review-and-meta-analysis
#36
Jiaqi Yan, Chaorong Zhang, Yuanping Wang, Xia Yan, Lili Jin
BACKGROUND: Although Shen Gui capsules (SGCP) are widely used as an adjuvant treatment for chronic heart failure (CHF), their clinical efficacy and safety remain controversial. PURPOSE: To assess the efficacy and safety of SGCP in the treatment of CHF through a systematic review and meta-analysis, to provide high-quality evidence for evidence-based medicine. METHODS: Seven databases were searched for randomized controlled trials (RCTs) assessing SGCP for CHF, from inception to 9 January 2023...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38658000/risk-stratification-and-prognosis-prediction-using-cardiac-biomarkers-in-covid-19-a-single-centre-retrospective-cohort-study
#37
JOURNAL ARTICLE
Madoka Sano, Toshiaki Toyota, Takeshi Morimoto, Yu Noguchi, Ryo Shigeno, Ryosuke Murai, Taiji Okada, Yasuhiro Sasaki, Tomohiko Taniguchi, Kitae Kim, Atsushi Kobori, Natsuhiko Ehara, Makoto Kinoshita, Asako Doi, Keisuke Tomii, Yasuki Kihara, Yutaka Furukawa
OBJECTIVE: There is a need for a robust tool to stratify the patient's risk with COVID-19. We assessed the prognostic values of cardiac biomarkers for COVID-19 patients. METHODS: This is a single-centre retrospective cohort study. Consecutive laboratory-confirmed COVID-19 patients admitted to the Kobe City Medical Center General Hospital from July 2020 to September 2021 were included. We obtained cardiac biomarker values from electronic health records and institutional blood banks...
April 23, 2024: BMJ Open
https://read.qxmd.com/read/38657739/blood-urea-nitrogen-to-serum-albumin-ratio-as-a-new-indicator-of-disease-severity-and-prognosis-in-idiopathic-pulmonary-artery-hypertension
#38
JOURNAL ARTICLE
Sicheng Zhang, Luyang Gao, Zhihui Zhao, Qing Zhao, Tao Yang, Qixian Zeng, Yi Zhang, Xin Li, Zhihua Huang, Anqi Duan, Qin Luo, Zhihong Liu
BACKGROUND: Emerging evidence has shown that the blood urea nitrogen to serum albumin ratio (BAR) is associated with the severity and prognosis of heart failure. However, its role in idiopathic pulmonary arterial hypertension (IPAH) remains unclear. This study investigated the associations between BAR and functional status, echocardiographic findings, hemodynamics, and long-term outcomes among patients with IPAH. METHODS: This study included consecutive patients who underwent right heart catheterization (RHC) and were diagnosed with IPAH between January 2013 and January 2018 at Fuwai Hospital...
April 22, 2024: Respiratory Medicine
https://read.qxmd.com/read/38655359/the-impact-of-serum-bnp-on-retinal-perfusion-assessed-by-an-ai-based-denoising-optical-coherence-tomography-angiography-in-chd-patients
#39
JOURNAL ARTICLE
Jin Wang, Huan Weng, Yiwen Qian, Yuceng Wang, Luoziyi Wang, Xin Wang, Pei Zhang, Zhiliang Wang
BACKGROUND: To investigate the correlation between retinal vessel density (VD) parameters with serum B-type natriuretic peptide (BNP) in patients with coronary heart disease (CHD) using novel optical coherence tomography angiography (OCTA) denoising images based on artificial intelligence (AI). METHODS: OCTA images of the optic nerve and macular area were obtained using a Canon-HS100 OCT device in 176 patients with CHD. Baseline information and blood test results were recorded...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38654208/fractional-exhaled-nitric-oxide-in-idiopathic-pulmonary-arterial-hypertension-and-mixed-connective-tissue-disease-complicating-pulmonary-hypertension
#40
JOURNAL ARTICLE
Jianhua Xu, Xingxing Sun, Yuan Cao, Hanqing Zhu, Wenlan Yang, Jinming Liu, Jian Guo
BACKGROUND: Fractional exhaled nitric oxide (FeNO) has been extensively studied in various causes of pulmonary hypertension (PH), but its utility as a noninvasive marker remains highly debated. The objective of our study was to assess FeNO levels in patients with idiopathic pulmonary arterial hypertension (IPAH) and mixed connective tissue disease complicating pulmonary hypertension (MCTD-PH), and to correlate them with respiratory functional data, disease severity, and cardiopulmonary function...
April 23, 2024: BMC Pulmonary Medicine
keyword
keyword
161620
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.